Business
NEW CHIEF EXECUTIVE OFFICER INVESTORS UPDATE
NEW CHIEF EXECUTIVE OFFICER INVESTORS UPDATE Canada NewsWire /NOT FOR DISTRIBUTION...
About this update from Seegnal Inc.
[{"type":"text","content":"\n\n\nNEW CHIEF EXECUTIVE OFFICER INVESTORS UPDATE\n\n/* Style Definitions */\nspan.prnews_span\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\na.prnews_a\n{\ncolor:blue;\n}\nli.prnews_li\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\np.prnews_p\n{\nfont-size:0.62em;\nfont-family:\"Arial\";\ncolor:black;\nmargin:0in;\n}\n.prnml40{\nMARGIN-LEFT:3.33em !IMPORTANT\n}\n.prntac{\nTEXT-ALIGN: CENTER\n}\n\n\n\n\n\nCanada NewsWire\n\n\n/NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES/\nCALGARY, AB, Dec. 23, 2025 /CNW/ - on behalf of Seegnal Inc. (TSXV: SEGN) (\"Seegnal\" or the \"Corporation\"), a global leader in SaaS clinical division support solutions for detecting and resolving drug-related problems, Mr. Elad Bibi-Aviv, Chief Executive Officer of Seegnal Inc. is pleased to update as follows:\nDear Seegnal Investors,\nWishing you and your families a warm holiday season and a healthy, successful New Year. Thank you for your continued support of Seegnal.\nVery recently, on December 16th, 2025 I have officially started as Seegnal's CEO and have spent these first days in tenure listening closely-to clinicians, health-system leaders, payers/insurers, partners, and our team members across the board. A consistent message has emerged: healthcare is being asked to deliver safer, more consistent outcomes amid rising complexity and capacity constraints.\nI have built and led healthcare technology initiatives at the intersection of clinical practice, data, and operational execution-focused on turning complex care decisions into measurable, scalable outcomes. I joined Seegnal to build the Intelligence Layer of Prescriptions and bring governance and trust to prescribing at scale.\nThe reason I joined Seegnal is that we are not starting from a concept - we are starting from real-world use, measurable engagement, and momentum. Seegnal's platform analyses more than 400,000 prescriptions per day, has analyzed over 174 million prescriptions in total, and over 20,000 clinicians currently use the platform, based on Seegnal's internal client information. More importantly, we're already seeing what becomes possible when prescribing moves from reactive to intelligent: measurable clinical benefit, smarter resource use, and reduced operational drag across the system.\nA key advantag...